Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Post AHSCT (Autologous Hematopoietic Stem Cell Transplantation) management for patients with systemic sclerosis: a prospective, non-interventional approach across Europe (NISSC-2)

Non-interventional Prospective Studies

Autoimmune Diseases Working Party (ADWP)

Type de traitement

Investigateur principal

Pr Dominique Farge

Trend and outcome of HSCT in Thalassemia inside the EBMT

Retrospective Studies

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Baronciani Donatella

Tendances et résultats de la greffe de cellules souches hématopoïétiques (GCSH) dans la thalassémie au sein de l’EBMT

Études rétrospectives

Autres anomalies non malignes

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Baronciani Donatella

Impact of AB0 Incompatibility on HSCT outcome in hemoglobinopathies: A Retrospective Registry Study from the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Retrospective Studies

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Katharina Kleinschmidt

Outcomes after graft failure of allogeneic hematopoietic stem cell transplantation in patients with SCD

Retrospective Studies

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Josu de la Fuente

The impact of pre-transplant extramedullary disease on the outcome of allogeneic hematopoietic cell transplantation for Acute Myeloid Leukemia in Children- A combined CIBMTR and EBMT analysis

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Patients who undergo a Stem cell Transplant may be at risk of being admitted to the PICU

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Myeloablative conditioning for allo-HSCT in pediatric ALL and AML below 2 years

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

André Willasch

CAR-T Data Collection Initiative

Post Authorization Safety (PAS) Studies

Acute Lymphatic Leukaemia (ALL)

Non-Hodgkin’s Lymphoma (NHL)

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Fecal transplant FOR GVHD

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Dr. J. Bilinski

Complications of CTX-based haploidentical stem cell transplantation – prospective observational study

Non-interventional Prospective Studies

Transplant Complications Working Party (TCWP)

Type de traitement

Allogeneic - Haploidentical

Investigateur principal

COLLECTION OF NEXT-GENERATION SEQUENCING (NGS) DATA AND USE OF NOVEL DRUGS IN ACUTE LEUKEMIA PATIENTS

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Acute Myeloid Leukaemia (AML)

Acute Leukemia Working Party (ALWP)

Type de traitement

Investigateur principal